Genetic variations in triple-negative breast cancers undergoing neo-adjuvant chemotherapy

Aim: Triple negative breast cancer (TNBC) is known as aggressive subtype and have no identified targeted therapies. We examined the relationship of neoadjuvant chemotherapy response to genetic variations of TNBC. Methods: The tumors used in this study were collected from Showa University Hospital, J...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Miki, Watanabe, Tomoko, Akashi-Tanaka, Sadako, Ueda, Kumiko, Makino, Reiko, Hirota, Yuko, Nakamura, Seigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992525/
https://www.ncbi.nlm.nih.gov/pubmed/35582572
http://dx.doi.org/10.20517/cdr.2019.44

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992525/
https://www.ncbi.nlm.nih.gov/pubmed/35582572
http://dx.doi.org/10.20517/cdr.2019.44

Ejemplares similares